South Korea is one of the few countries considered to have controlled hypertension thanks to concerted policy over the past 15 years. Faith McLellan reports.
DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results